A practical reference on anti-doping: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
The first step was witnessed on live television by at least one-fifth of the population of Earth, or about 723 million people. His first words when he stepped off the LM's landing footpad were, "That's one small step for [a] man, one giant leap for mankind." Aldrin joined him on the surface almost 20 minutes later. Altogether, they spent just under two and one-quarter hours outside their craft. The next day, they performed the first crewed launch from another celestial body, and rendezvoused back with Collins in Columbia. But before they return ascended the Space Race came to a particular culmination. A few days before Apollo 11 left Earth, the Soviet Union launched the Luna 15 probe, entering lunar orbit just before Apollo 11 and eventually sharing it with Apollo 11. Aware of Luna 15, Apollo 8 astronaut Frank Borman was asked to use his goodwill contacts in the Soviet Union to prevent any collision. Subsequently, in one of the first instances of Soviet–American space communication the Soviet Union released Luna 15's flight plan to ensure it would not collide with Apollo 11, although its exact mission was not publicized. But as Apollo 11 was wrapping up surface activities, the Soviet mission command hastened Luna 15 and attempted its robotic sample-return mission before Apollo 11 would return. As Luna 15 descended just two hours before Apollo 11's launch and impacted at 15:50 UTC some hundred kilometers away from Apollo 11, British astronomers monitoring Luna 15 recorded the situation, with one commenting:"I say, this has really been drama of the highest order".
==== Heavier alkali metals ==== Unlike the organolithium compounds, the organometallic compounds of the heavier alkali metals are predominantly ionic. The application of organosodium compounds in chemistry is limited in part due to competition from organolithium compounds, which are commercially available and exhibit more convenient reactivity. The principal organosodium compound of commercial importance is sodium cyclopentadienide. Sodium tetraphenylborate can also be classified as an organosodium compound since in the solid state sodium is bound to the aryl groups. Organometallic compounds of the higher alkali metals are even more reactive than organosodium compounds and of limited utility. A notable reagent is Schlosser's base, a mixture of n-butyllithium and potassium tert-butoxide. This reagent reacts with propene to form the compound allylpotassium (KCH2CHCH2). cis-2-Butene and trans-2-butene equilibrate when in contact with alkali metals. Whereas isomerisation is fast with lithium and sodium, it is slow with the heavier alkali metals. The heavier alkali metals also favour the sterically congested conformation. Several crystal structures of organopotassium compounds have been reported, establishing that they, like the sodium compounds, are polymeric. Organosodium, organopotassium, organorubidium and organocaesium compounds are all mostly ionic and are insoluble (or nearly so) in nonpolar solvents. Alkyl and aryl derivatives of sodium and potassium tend to react with air. They cause the cleavage of ethers, generating alkoxides.
== Styles == Most categorical alcoholic beverages have regulations governing their classification and labelling, while those governing absinthe have always been conspicuously lacking. According to popular treatises from the 19th century, absinthe could be loosely categorised into several grades (ordinaire, demi-fine, fine, and Suisse – the latter does not denote origin), in order of increasing alcoholic strength and quality. Many contemporary absinthe critics simply classify absinthe as distilled or mixed, according to its production method. And while the former is generally considered far superior in quality to the latter, an absinthe's simple claim of being 'distilled' makes no guarantee as to the quality of its base ingredients or the skill of its maker.
There are three main fermentation methods, warm, cool, and wild or spontaneous. Fermentation may take place in open or closed vessels. There may be a secondary fermentation which can take place in the brewery, in the cask or in the bottle. Brewing yeasts have traditionally been described as "top-fermenting" or "bottom-fermenting", and may be "top-cropped" or "bottom-cropped" according to where the yeast is collected from the fermentation vessel to be reused for the next brew. The yeasts classed as top-fermenting are generally used in warm fermentations, where they ferment quickly, and the yeasts classed as bottom-fermenting are used in cooler fermentations where they ferment more slowly. This terminology is somewhat inappropriate in the modern era; after the widespread application of brewing mycology it was discovered that the two separate collecting methods involved two different yeast species that favoured different temperature regimes, namely Saccharomyces cerevisiae in top-cropping at warmer temperatures and Saccharomyces pastorianus in bottom-cropping at cooler temperatures. As brewing methods changed in the 20th century, cylindro-conical fermenting vessels became the norm and the collection of yeast for both Saccharomyces species is done from the bottom of the fermenter. Thus the method of collection no longer implies a species association. There are a few remaining breweries who collect yeast by top-cropping, such as Samuel Smith's in Yorkshire using Yorkshire Squares, and several German hefeweizen producers.
== Further reading == Jackie Y. Ying (2001). Nanostructured Materials. Academic Press. pp. 5–. ISBN 978-0-12-744451-2. Nanoparticles Used in Solar Energy Conversion (ScienceDaily). "Nanoparticles: An occupational hygiene review" Archived 24 September 2015 at the Wayback Machine by RJ Aitken and others. Health and Safety Executive Research Report 274/2004 "EMERGNANO: A review of completed and near completed environment, health and safety research on nanomaterials and nanotechnology" by RJ Aitken and others. High transmission Tandem DMA for nanoparticle studies by SEADM, 2014.
Sources: en.wikipedia.org
So in Victoria University of Technology v Wilson it was held that when a professor developed profitable software it was not within the scope of his contractual duty, but as a senior leader he had a duty to avoid conflicts of interest with the university and should have asked the university's consent to pursue the opportunity for himself. This meant he had to give up all the profits from the invention. Indefinite employment contracts can be terminated upon reasonable notice (so long as this does not contradict express terms, other implied terms or statutory rights such as a fair process), and the employee must provide work to be paid. Second, there are implied terms that benefit employees. Employers owe a common law duty of reasonable care to avoid putting employees at unnecessary risks of harm, because 'the employer is in a position to direct another to go into harm's way'. Where there are risks, an employer ensure it 'eliminates the risk' or provides 'adequate safeguards'. For instance in Patrick Stevedores v Vaughan an employer breached its duty by ordering a supervisor to cross a picket line to go to work, when it had instigated a violent dispute through its actions, and the supervisor suffered traumatic stress. However in Koehler v Cerebos (Australia) Ltd the High Court refused a claim by a store merchandiser who was told to complete work in reduced hours, who suffered stress-related psychiatric illness, because it held that an employer can insist on performance of normal contractual duties, and overwork was not foreseeable.
=== Patient information === Blood Transfusion Leaflets (NHS Blood and Transplant) Blood Transfusion Leaflets (Welsh Blood Service) Blood Transfusion Information (Scotland) Blood Transfusion Information (Australia) Blood Transfusion Information (American Cancer Society)
== Causes == VERBAS is usually caused by a nonsense mutation on the QRICH1 gene that happens sporadically. In 2023 a new autosomal-dominant gene was identified that was passed down from a mother to her daughter.
An insurgent was killed and eight captured in a military operation in the Greda Shah Jahan village of Bannu District, while three more alleged militants were captured from Saidu Sharif by police. Two children were injured in an insurgent mortar attack Dabar Malano Jalwaana area of Wara Mamund tehsil. On 20 July, four militants were killed in a military operation in Lakrai area of Mohmand District while six were killed in raids throughout Bannu District, six IEDs were also neutralized in Bannu District. Three Excise Department personnel were abducted from a checkpoint on the Dalbandin–Taftan Highway in Chagai District. On 21 July, a peace committee member was assassinated by an IED attack in Karrapa area of Hangu District while TTP claimed to have killed two in the Muhammad Khel area of Boya Tehsil. The Wadigram area in Salarzai Tehsil was hit by two mortar shells while insurgents blew up a Government school in Mamund Tehsil. On 22 July, a TTP insurgent was captured from the Syed Ali Mela Khor area of Kurram District while three were captured from Khyber District, three more were killed in a military operation in Chapri Naryab Chowk area of Hangu District. On 23 July, insurgents ambushed and killed a Police Constable near Moula Khan Sarai in the Sarwekai area of South Waziristan District. Four TTP militants were killed and five captured in a military operation in Talgai mountains of Wazir Tehsil, while two militant hideouts were destroyed in the Sipah Tandi Kalay area of Bara.
Chorea-acanthocytosis (ChAc, also called choreoacanthocytosis) is a rare hereditary disease—evidence suggests that only 500 to 1,000 people worldwide have the condition. It is caused by a mutation in a gene that directs structural proteins in red blood cells. It belongs to a group of four diseases characterized under the name neuroacanthocytosis. When a patient's blood is viewed under a microscope, some of the red blood cells appear thorny. These thorny cells are called acanthocytes. Other effects of the disease may include involuntary muscle movements, impaired balance and coordination, behavioral changes, memory problems, difficulty swallowing, speech difficulties, seizures, muscle weakness, personality changes, and neuronal degradation similar to Huntington's disease. The average age of onset of symptoms is 35 years. The disease is incurable and inevitably leads to premature death. Chorea-acanthocytosis is a very complex autosomal recessive adult-onset neurodegenerative disorder. It often shows itself as a mixed movement disorder, in which chorea, tics, dystonia and even parkinsonism may appear as a symptom. This disease is also characterized by the presence of a few different movement disorders including chorea, dystonia etc. Chorea-acanthocytosis is considered an autosomal recessive disorder, although a few cases with autosomal dominant inheritance have been noted.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.